Lifsa Drugs
UEI: UA3LMNYNN4B4
• CAGE: 16RY6
Overview
Awardee Type
Parent
Name
Lifsa Drugs
Website
Headquarters
North Brunswick, NJ
United States
United States
Federal recipient
LIFSA DRUGS LLC
(UEI UA3LMNYNN4B4, CAGE 16RY6)
is headquartered in North Brunswick NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The sole proprietorship
was founded in April 2018 and
federally registered in
October 2025.
Federal Registration and Certifications
Legal Name
LIFSA DRUGS LLC
UEI
UA3LMNYNN4B4
CAGE Code
16RY6
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Sole Proprietorship
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 24, 2018
Initial Registration
Oct. 23, 2025
Last Registration
Nov. 24, 2025
Registration Activation
Nov. 20, 2025
Registration Expiration
Nov. 12, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Country of Incorporation
None
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Lifsa Drugs
GSA Schedules and Price Lists
- Lifsa Drugs
- PoP: 6/2/26 - 11/30/26